SCHEMBL19872020

SCHEMBL19872020

CC(C)(C)CCCCOc1nsnc1N1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
MAPK1 P28482 3/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
TSHR P16473 2/20 0.56
HTT P42858 3/20 0.56
HPGD P15428 2/20 0.56
KMT2A Q03164 5/20 0.56
TDP1 Q9NUW8 2/20 0.54
CYP1A2 P05177 1/20 0.54
ADRB2 P07550 1/20 0.54
ADRB1 P08588 1/20 0.54
CYP3A4 P08684 1/20 0.54
HTR1A P08908 1/20 0.54
CYP2D6 P10635 1/20 0.54
ADRB3 P13945 1/20 0.54
NFKB1 P19838 1/20 0.54
DRD1 P21728 1/20 0.54
SIGMAR1 Q99720 1/20 0.54
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18938268 0.82 TDP1 (0.64) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL23789618 0.81 ALDH1A1 (0.52) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL19870486 0.78 CYP1A2 (0.71) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL13953865 0.78 KMT2A (0.69) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL21688539 0.77 HTT (0.53) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL21505040 0.76 TDP1 (0.46) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL21505038 0.75 ALDH1A1 (0.51) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL18074878 0.75 CYP1A2 (0.63) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL4433592 0.74 CYP1A2 (0.56) ALDH1A1MAPK1ALOX15HSD17B10TSHR
SCHEMBL21814399 0.74 ALDH1A1 (0.51) ALDH1A1MAPK1ALOX15HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180042932-A1 COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE ALLERGAN SALES LLC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180042932-A1 COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE ADRB2, ADRA2B, PDE3B ALDH1A1 2506/4885MAPK1 3538/4885ALOX15 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.